FDA Decision On Interchangeable Exclusivity Allows Pfizer To Rival Boehringer On Adalimumab
Humira Biosimilar Abrilada Is Now Interchangeable; Pfizer Reveals Launch And Pricing Details
• By David Wallace
The FDA decision has ended Boehringer’s exclusivity period • Source: Shutterstock 
